|
|
Article: Adamas Pharmaceuticals Selects Veeva CRM to Support New Product Commercialization and Anticipated Growth.
- Article from:
- Biotech Week
- Article date:
- November 11, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Adamas Pharmaceuticals, an emerging pharmaceutical company focused on developing small-molecule therapeutics to treat neurological and infectious diseases, selected Veeva System's VBioPharma™ KOL Edition - part of the Veeva CRM suite. Selection of Veeva's SaaS solution marks an important step in Adamas' early-stage product commercialization strategy. Veeva CRM is currently being rolled out to Adamas' customer facing teams in sales and marketing and clinical management, and will scale with the company as it grows (see also Veeva Systems, Inc.).
Adamas initially considered making the heavy investment in a custom-built system that would support the company's ...